4,44 $
0,45 % gestern
Nasdaq, 30. Oktober, 21:00 Uhr
ISIN
US30205M1018
Symbol
XCUR
Berichte

Exicure Inc Aktie News

Neutral
Business Wire
8 Tage alt
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Exicure, Inc. (NASDAQ: XCUR) breached their fiduciary duties to shareholders. If you currently own Exicure stock and acquired shares on or before January 7, 2021, you may be able to seek corporate governance reforms, the return of funds back to the company, a cour...
Neutral
GlobeNewsWire
25 Tage alt
Burixafor (GPC-100) Phase 2 Trial in Multiple Myeloma Nears Key Readout Preparing for Expansion into Sickle Cell Disease and Acute Myeloid Leukemia New Leadership Appointments Bring Deep Drug Development Expertise REDWOOD CITY, Calif., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Exicure, Inc. (Nasdaq: XCUR), a clinical-stage biotechnology company developing therapeutics for hematologic diseases, today sh...
Negativ
The Motley Fool
3 Monate alt
Exicure Posts Wider Loss in Fiscal Q2
Neutral
Business Wire
3 Monate alt
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Exicure, Inc. Reports Second Quarter 2025 Financial Results.
Neutral
Business Wire
3 Monate alt
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Exicure, Inc. (Nasdaq: XCUR) Regains Compliance with Nasdaq Filing Requirements.
Neutral
Business Wire
3 Monate alt
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Exicure Completes the Last Patient, Last Visit in Phase 2 Study of GPC-100 for Stem Cell Mobilization in Multiple Myeloma Patients.
Neutral
Business Wire
4 Monate alt
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Q1 2025 earnings release.
Neutral
Business Wire
5 Monate alt
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-Q.

Kostenlos registrieren

aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.

Die Apple Aktie im Überblick mit Charts, aktuellen Kennzahlen, Nachrichten und Aktienanalysen.
Die besten Dividenden-Aktien in der Dividenden-Topscorer-Liste.
Aktienanalysen der besten Aktien weltweit.
Jetzt Vermögen aufbauen